Home/Filings/4/0001493152-22-035985
4//SEC Filing

Wolfe Peter 4

Accession 0001493152-22-035985

CIK 0001859007other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:00 PM ET

Size

5.1 KB

Accession

0001493152-22-035985

Insider Transaction Report

Form 4
Period: 2022-12-16
Wolfe Peter
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-12-16$2.88/sh+3,000$8,64544,585 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.78 to $2.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Documents

1 file

Issuer

ZyVersa Therapeutics, Inc.

CIK 0001859007

Entity typeother

Related Parties

1
  • filerCIK 0001954398

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:00 PM ET
Size
5.1 KB